These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 2933617)
1. Hormonal treatment of disseminated male breast cancer. Lopez M; Di Lauro L; Lazzaro B; Papaldo P Oncology; 1985; 42(6):345-9. PubMed ID: 2933617 [TBL] [Abstract][Full Text] [Related]
2. On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer. Petru E; Schmähl D Klin Wochenschr; 1987 Oct; 65(20):959-66. PubMed ID: 2963170 [TBL] [Abstract][Full Text] [Related]
3. Hormonal therapy for metastatic male breast cancer. Kantarjian H; Yap HY; Hortobagyi G; Buzdar A; Blumenschein G Arch Intern Med; 1983 Feb; 143(2):237-40. PubMed ID: 6824391 [TBL] [Abstract][Full Text] [Related]
4. [Hormonal control of disseminated breast cancer]. Voznyĭ EK; Meshcheriakova NG; Biakhov MIu; Vasiuta NIu Sov Med; 1990; (6):94-7. PubMed ID: 2144368 [No Abstract] [Full Text] [Related]
5. Endocrine treatment with anti-estrogen, anti-androgen or progestagen of advanced malignant melanoma: three consecutive phase II trials. Rose C; Pedersen L; Mouridsen HT Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1171-4. PubMed ID: 2934258 [TBL] [Abstract][Full Text] [Related]
6. Additive hormonal therapy in women with advanced breast cancer. Ingle JN Cancer; 1984 Feb; 53(3 Suppl):766-77. PubMed ID: 6229323 [TBL] [Abstract][Full Text] [Related]
7. EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group. Pavone-Macaluso M; Schröder FH; de Voogt HJ; Viggiano G; Barasolo E; Lardennois B; de Pauw M; Sylvester R; Smith PH; Suciu S Prog Clin Biol Res; 1989; 303():111-6. PubMed ID: 2528735 [No Abstract] [Full Text] [Related]
8. Hormonal therapy trials in prostatic cancer. An EORTC Genitourinary Group study. Bollack C; Rougeron G Am J Clin Oncol; 1988; 11 Suppl 2():S156-9. PubMed ID: 2977270 [TBL] [Abstract][Full Text] [Related]
9. [Endocrine therapy of breast cancer]. Jonat W; Maass H Zentralbl Gynakol; 1987; 109(10):617-27. PubMed ID: 2956805 [TBL] [Abstract][Full Text] [Related]
10. [Adjuvant hormone therapy of primary breast cancer. Review of the literature]. Focan C Rev Med Liege; 1991 May; 46(5):270-8. PubMed ID: 1830160 [No Abstract] [Full Text] [Related]
11. [Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer]. Szepesi T; Schratter-Sehn AU Wien Klin Wochenschr; 1982 Sep; 94(17):463-9. PubMed ID: 6760557 [TBL] [Abstract][Full Text] [Related]
12. Randomized trial comparing aminoglutethimide with high-dose medroxyprogesterone acetate in therapy for advanced breast carcinoma. Canney PA; Priestman TJ; Griffiths T; Latief TN; Mould JJ; Spooner D J Natl Cancer Inst; 1988 Sep; 80(14):1147-51. PubMed ID: 2970555 [TBL] [Abstract][Full Text] [Related]
13. [Male transsexualism and hormonal therapy: radiologic pictures of the breast]. Godano A; Massara D; Grassi G; Genovese MG; Cavallotti GP; Bocchini R Arch Ital Urol Nefrol Androl; 1990 Mar; 62(1):107-11. PubMed ID: 2141702 [TBL] [Abstract][Full Text] [Related]
14. The hormonal treatment of sexual offenders. Bradford JM Bull Am Acad Psychiatry Law; 1983; 11(2):159-69. PubMed ID: 6225477 [No Abstract] [Full Text] [Related]
15. Management of breast cancer. Cohen IA; Keller JH; Abate MA Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963 [TBL] [Abstract][Full Text] [Related]
16. Tamoxifen therapy of metastatic breast cancer. Manni A J Lab Clin Med; 1987 Mar; 109(3):290-9. PubMed ID: 2950193 [TBL] [Abstract][Full Text] [Related]
17. [Value of hormone therapy in metastasizing breast cancer]. Samonigg H Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208 [TBL] [Abstract][Full Text] [Related]
18. [Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study]. Wander HE; Kleeberg UR; Essers U; Blossey HC; Nagel GA Onkologie; 1987 Oct; 10(5):321-3. PubMed ID: 2960938 [No Abstract] [Full Text] [Related]
19. Cancer of the breast. Endocrine and hormonal therapy. Kardinal CG; Donegan WL Major Probl Clin Surg; 1979; 5():361-404. PubMed ID: 379452 [TBL] [Abstract][Full Text] [Related]